Global Antacid Market Research Report 2023

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Highlights

The global Antacid market was valued at US$ 6219 million in 2022 and is anticipated to reach US$ 7835.8 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029.

The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.

In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antacid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antacid.

The Antacid market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antacid market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antacid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

AstraZeneca

Takeda Pharmaceutical

Pfizer

Reckitt Benckiser

Bayer

Procter＆Gamble

GlaxoSmithKline

Johnson＆Johnson

CONBA

Xiuzheng Pharma

Sanofi

Bausch Health

CR SANJIU

Reddy's Laboratories

Proton Pump Inhibitor

H2 Antagonist

Acid Neutralizers

OTC Drug

Rx Drug

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Antacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Antacid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

1.1 Product Overview and Scope of Antacid

1.2 Antacid Segment by Type

1.2.1 Global Antacid Market Value Comparison by Type (2023-2029)

1.2.2 Proton Pump Inhibitor

1.2.3 H2 Antagonist

1.2.4 Acid Neutralizers

1.3 Antacid Segment by Application

1.3.1 Global Antacid Market Value by Application: (2023-2029)

1.3.2 OTC Drug

1.3.3 Rx Drug

1.4 Global Antacid Market Size Estimates and Forecasts

1.4.1 Global Antacid Revenue 2018-2029

1.4.2 Global Antacid Sales 2018-2029

1.4.3 Global Antacid Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Antacid Sales Market Share by Manufacturers (2018-2023)

2.2 Global Antacid Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Antacid Average Price by Manufacturers (2018-2023)

2.4 Global Antacid Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Antacid, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antacid, Product Type & Application

2.7 Antacid Market Competitive Situation and Trends

2.7.1 Antacid Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Antacid Players Market Share by Revenue

2.7.3 Global Antacid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Antacid Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Antacid Global Antacid Sales by Region: 2018-2029

3.2.1 Global Antacid Sales by Region: 2018-2023

3.2.2 Global Antacid Sales by Region: 2024-2029

3.3 Global Antacid Global Antacid Revenue by Region: 2018-2029

3.3.1 Global Antacid Revenue by Region: 2018-2023

3.3.2 Global Antacid Revenue by Region: 2024-2029

3.4 North America Antacid Market Facts & Figures by Country

3.4.1 North America Antacid Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Antacid Sales by Country (2018-2029)

3.4.3 North America Antacid Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Antacid Market Facts & Figures by Country

3.5.1 Europe Antacid Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Antacid Sales by Country (2018-2029)

3.5.3 Europe Antacid Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antacid Market Facts & Figures by Country

3.6.1 Asia Pacific Antacid Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Antacid Sales by Country (2018-2029)

3.6.3 Asia Pacific Antacid Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Antacid Market Facts & Figures by Country

3.7.1 Latin America Antacid Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Antacid Sales by Country (2018-2029)

3.7.3 Latin America Antacid Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antacid Market Facts & Figures by Country

3.8.1 Middle East and Africa Antacid Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Antacid Sales by Country (2018-2029)

3.8.3 Middle East and Africa Antacid Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Antacid Sales by Type (2018-2029)

4.1.1 Global Antacid Sales by Type (2018-2023)

4.1.2 Global Antacid Sales by Type (2024-2029)

4.1.3 Global Antacid Sales Market Share by Type (2018-2029)

4.2 Global Antacid Revenue by Type (2018-2029)

4.2.1 Global Antacid Revenue by Type (2018-2023)

4.2.2 Global Antacid Revenue by Type (2024-2029)

4.2.3 Global Antacid Revenue Market Share by Type (2018-2029)

4.3 Global Antacid Price by Type (2018-2029)

5.1 Global Antacid Sales by Application (2018-2029)

5.1.1 Global Antacid Sales by Application (2018-2023)

5.1.2 Global Antacid Sales by Application (2024-2029)

5.1.3 Global Antacid Sales Market Share by Application (2018-2029)

5.2 Global Antacid Revenue by Application (2018-2029)

5.2.1 Global Antacid Revenue by Application (2018-2023)

5.2.2 Global Antacid Revenue by Application (2024-2029)

5.2.3 Global Antacid Revenue Market Share by Application (2018-2029)

5.3 Global Antacid Price by Application (2018-2029)

6.1 AstraZeneca

6.1.1 AstraZeneca Corporation Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Antacid Sales, Revenue and Gross Margin (2018-2023)

6.1.4 AstraZeneca Antacid Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Takeda Pharmaceutical

6.2.1 Takeda Pharmaceutical Corporation Information

6.2.2 Takeda Pharmaceutical Description and Business Overview

6.2.3 Takeda Pharmaceutical Antacid Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Takeda Pharmaceutical Antacid Product Portfolio

6.2.5 Takeda Pharmaceutical Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Antacid Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Antacid Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Reckitt Benckiser

6.4.1 Reckitt Benckiser Corporation Information

6.4.2 Reckitt Benckiser Description and Business Overview

6.4.3 Reckitt Benckiser Antacid Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Reckitt Benckiser Antacid Product Portfolio

6.4.5 Reckitt Benckiser Recent Developments/Updates

6.5 Bayer

6.5.1 Bayer Corporation Information

6.5.2 Bayer Description and Business Overview

6.5.3 Bayer Antacid Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Bayer Antacid Product Portfolio

6.5.5 Bayer Recent Developments/Updates

6.6 Procter＆Gamble

6.6.1 Procter＆Gamble Corporation Information

6.6.2 Procter＆Gamble Description and Business Overview

6.6.3 Procter＆Gamble Antacid Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Procter＆Gamble Antacid Product Portfolio

6.6.5 Procter＆Gamble Recent Developments/Updates

6.7 GlaxoSmithKline

6.6.1 GlaxoSmithKline Corporation Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Antacid Sales, Revenue and Gross Margin (2018-2023)

6.4.4 GlaxoSmithKline Antacid Product Portfolio

6.7.5 GlaxoSmithKline Recent Developments/Updates

6.8 Johnson＆Johnson

6.8.1 Johnson＆Johnson Corporation Information

6.8.2 Johnson＆Johnson Description and Business Overview

6.8.3 Johnson＆Johnson Antacid Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Johnson＆Johnson Antacid Product Portfolio

6.8.5 Johnson＆Johnson Recent Developments/Updates

6.9 CONBA

6.9.1 CONBA Corporation Information

6.9.2 CONBA Description and Business Overview

6.9.3 CONBA Antacid Sales, Revenue and Gross Margin (2018-2023)

6.9.4 CONBA Antacid Product Portfolio

6.9.5 CONBA Recent Developments/Updates

6.10 Xiuzheng Pharma

6.10.1 Xiuzheng Pharma Corporation Information

6.10.2 Xiuzheng Pharma Description and Business Overview

6.10.3 Xiuzheng Pharma Antacid Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Xiuzheng Pharma Antacid Product Portfolio

6.10.5 Xiuzheng Pharma Recent Developments/Updates

6.11 Sanofi

6.11.1 Sanofi Corporation Information

6.11.2 Sanofi Antacid Description and Business Overview

6.11.3 Sanofi Antacid Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Sanofi Antacid Product Portfolio

6.11.5 Sanofi Recent Developments/Updates

6.12 Bausch Health

6.12.1 Bausch Health Corporation Information

6.12.2 Bausch Health Antacid Description and Business Overview

6.12.3 Bausch Health Antacid Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Bausch Health Antacid Product Portfolio

6.12.5 Bausch Health Recent Developments/Updates

6.13 CR SANJIU

6.13.1 CR SANJIU Corporation Information

6.13.2 CR SANJIU Antacid Description and Business Overview

6.13.3 CR SANJIU Antacid Sales, Revenue and Gross Margin (2018-2023)

6.13.4 CR SANJIU Antacid Product Portfolio

6.13.5 CR SANJIU Recent Developments/Updates

6.14 Reddy's Laboratories

6.14.1 Reddy's Laboratories Corporation Information

6.14.2 Reddy's Laboratories Antacid Description and Business Overview

6.14.3 Reddy's Laboratories Antacid Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Reddy's Laboratories Antacid Product Portfolio

6.14.5 Reddy's Laboratories Recent Developments/Updates

7.1 Antacid Industry Chain Analysis

7.2 Antacid Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antacid Production Mode & Process

7.4 Antacid Sales and Marketing

7.4.1 Antacid Sales Channels

7.4.2 Antacid Distributors

7.5 Antacid Customers

8.1 Antacid Industry Trends

8.2 Antacid Market Drivers

8.3 Antacid Market Challenges

8.4 Antacid Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Antacid Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Antacid Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Antacid Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Antacid Sales (M Units) of Key Manufacturers (2018-2023)

    Table 5. Global Antacid Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Antacid Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Antacid Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Antacid Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Antacid, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Antacid, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Antacid, Product Type & Application

    Table 12. Global Key Manufacturers of Antacid, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Antacid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antacid as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Antacid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Antacid Sales by Region (2018-2023) & (M Units)

    Table 18. Global Antacid Sales Market Share by Region (2018-2023)

    Table 19. Global Antacid Sales by Region (2024-2029) & (M Units)

    Table 20. Global Antacid Sales Market Share by Region (2024-2029)

    Table 21. Global Antacid Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Antacid Revenue Market Share by Region (2018-2023)

    Table 23. Global Antacid Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Antacid Revenue Market Share by Region (2024-2029)

    Table 25. North America Antacid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Antacid Sales by Country (2018-2023) & (M Units)

    Table 27. North America Antacid Sales by Country (2024-2029) & (M Units)

    Table 28. North America Antacid Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Antacid Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Antacid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Antacid Sales by Country (2018-2023) & (M Units)

    Table 32. Europe Antacid Sales by Country (2024-2029) & (M Units)

    Table 33. Europe Antacid Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Antacid Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Antacid Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Antacid Sales by Region (2018-2023) & (M Units)

    Table 37. Asia Pacific Antacid Sales by Region (2024-2029) & (M Units)

    Table 38. Asia Pacific Antacid Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Antacid Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Antacid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Antacid Sales by Country (2018-2023) & (M Units)

    Table 42. Latin America Antacid Sales by Country (2024-2029) & (M Units)

    Table 43. Latin America Antacid Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Antacid Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Antacid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Antacid Sales by Country (2018-2023) & (M Units)

    Table 47. Middle East & Africa Antacid Sales by Country (2024-2029) & (M Units)

    Table 48. Middle East & Africa Antacid Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Antacid Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Antacid Sales (M Units) by Type (2018-2023)

    Table 51. Global Antacid Sales (M Units) by Type (2024-2029)

    Table 52. Global Antacid Sales Market Share by Type (2018-2023)

    Table 53. Global Antacid Sales Market Share by Type (2024-2029)

    Table 54. Global Antacid Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Antacid Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Antacid Revenue Market Share by Type (2018-2023)

    Table 57. Global Antacid Revenue Market Share by Type (2024-2029)

    Table 58. Global Antacid Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Antacid Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Antacid Sales (M Units) by Application (2018-2023)

    Table 61. Global Antacid Sales (M Units) by Application (2024-2029)

    Table 62. Global Antacid Sales Market Share by Application (2018-2023)

    Table 63. Global Antacid Sales Market Share by Application (2024-2029)

    Table 64. Global Antacid Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Antacid Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Antacid Revenue Market Share by Application (2018-2023)

    Table 67. Global Antacid Revenue Market Share by Application (2024-2029)

    Table 68. Global Antacid Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Antacid Price (USD/Unit) by Application (2024-2029)

    Table 70. AstraZeneca Corporation Information

    Table 71. AstraZeneca Description and Business Overview

    Table 72. AstraZeneca Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. AstraZeneca Antacid Product

    Table 74. AstraZeneca Recent Developments/Updates

    Table 75. Takeda Pharmaceutical Corporation Information

    Table 76. Takeda Pharmaceutical Description and Business Overview

    Table 77. Takeda Pharmaceutical Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Takeda Pharmaceutical Antacid Product

    Table 79. Takeda Pharmaceutical Recent Developments/Updates

    Table 80. Pfizer Corporation Information

    Table 81. Pfizer Description and Business Overview

    Table 82. Pfizer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Pfizer Antacid Product

    Table 84. Pfizer Recent Developments/Updates

    Table 85. Reckitt Benckiser Corporation Information

    Table 86. Reckitt Benckiser Description and Business Overview

    Table 87. Reckitt Benckiser Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Reckitt Benckiser Antacid Product

    Table 89. Reckitt Benckiser Recent Developments/Updates

    Table 90. Bayer Corporation Information

    Table 91. Bayer Description and Business Overview

    Table 92. Bayer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Bayer Antacid Product

    Table 94. Bayer Recent Developments/Updates

    Table 95. Procter＆Gamble Corporation Information

    Table 96. Procter＆Gamble Description and Business Overview

    Table 97. Procter＆Gamble Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Procter＆Gamble Antacid Product

    Table 99. Procter＆Gamble Recent Developments/Updates

    Table 100. GlaxoSmithKline Corporation Information

    Table 101. GlaxoSmithKline Description and Business Overview

    Table 102. GlaxoSmithKline Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. GlaxoSmithKline Antacid Product

    Table 104. GlaxoSmithKline Recent Developments/Updates

    Table 105. Johnson＆Johnson Corporation Information

    Table 106. Johnson＆Johnson Description and Business Overview

    Table 107. Johnson＆Johnson Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Johnson＆Johnson Antacid Product

    Table 109. Johnson＆Johnson Recent Developments/Updates

    Table 110. CONBA Corporation Information

    Table 111. CONBA Description and Business Overview

    Table 112. CONBA Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. CONBA Antacid Product

    Table 114. CONBA Recent Developments/Updates

    Table 115. Xiuzheng Pharma Corporation Information

    Table 116. Xiuzheng Pharma Description and Business Overview

    Table 117. Xiuzheng Pharma Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Xiuzheng Pharma Antacid Product

    Table 119. Xiuzheng Pharma Recent Developments/Updates

    Table 120. Sanofi Corporation Information

    Table 121. Sanofi Description and Business Overview

    Table 122. Sanofi Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. Sanofi Antacid Product

    Table 124. Sanofi Recent Developments/Updates

    Table 125. Bausch Health Corporation Information

    Table 126. Bausch Health Description and Business Overview

    Table 127. Bausch Health Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. Bausch Health Antacid Product

    Table 129. Bausch Health Recent Developments/Updates

    Table 130. CR SANJIU Corporation Information

    Table 131. CR SANJIU Description and Business Overview

    Table 132. CR SANJIU Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 133. CR SANJIU Antacid Product

    Table 134. CR SANJIU Recent Developments/Updates

    Table 135. Reddy's Laboratories Corporation Information

    Table 136. Reddy's Laboratories Description and Business Overview

    Table 137. Reddy's Laboratories Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 138. Reddy's Laboratories Antacid Product

    Table 139. Reddy's Laboratories Recent Developments/Updates

    Table 140. Key Raw Materials Lists

    Table 141. Raw Materials Key Suppliers Lists

    Table 142. Antacid Distributors List

    Table 143. Antacid Customers List

    Table 144. Antacid Market Trends

    Table 145. Antacid Market Drivers

    Table 146. Antacid Market Challenges

    Table 147. Antacid Market Restraints

    Table 148. Research Programs/Design for This Report

    Table 149. Key Data Information from Secondary Sources

    Table 150. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Antacid

    Figure 2. Global Antacid Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Antacid Market Share by Type in 2022 & 2029

    Figure 4. Proton Pump Inhibitor Product Picture

    Figure 5. H2 Antagonist Product Picture

    Figure 6. Acid Neutralizers Product Picture

    Figure 7. Global Antacid Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Antacid Market Share by Application in 2022 & 2029

    Figure 9. OTC Drug

    Figure 10. Rx Drug

    Figure 11. Global Antacid Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Antacid Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Antacid Sales (2018-2029) & (M Units)

    Figure 14. Global Antacid Average Price (USD/Unit) & (2018-2029)

    Figure 15. Antacid Report Years Considered

    Figure 16. Antacid Sales Share by Manufacturers in 2022

    Figure 17. Global Antacid Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Antacid Players: Market Share by Revenue in 2022

    Figure 19. Antacid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Antacid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Antacid Sales Market Share by Country (2018-2029)

    Figure 22. North America Antacid Revenue Market Share by Country (2018-2029)

    Figure 23. U.S. Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Antacid Sales Market Share by Country (2018-2029)

    Figure 26. Europe Antacid Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Antacid Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Antacid Revenue Market Share by Region (2018-2029)

    Figure 34. China Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Taiwan Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Philippines Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Latin America Antacid Sales Market Share by Country (2018-2029)

    Figure 45. Latin America Antacid Revenue Market Share by Country (2018-2029)

    Figure 46. Mexico Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Brazil Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Argentina Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Antacid Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Antacid Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. U.A.E Antacid Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Antacid by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Antacid by Type (2018-2029)

    Figure 56. Global Antacid Price (USD/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Antacid by Application (2018-2029)

    Figure 58. Global Revenue Market Share of Antacid by Application (2018-2029)

    Figure 59. Global Antacid Price (USD/Unit) by Application (2018-2029)

    Figure 60. Antacid Value Chain

    Figure 61. Antacid Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed